Drugs / Nivolumab-800CW
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07196384 | Dec 2025 → Oct 2026 expected | esophageal cancer | University Medical Center Groningen | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nivolumab-800CW | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07196384 ↗ |